Covance, Inc. (NYSE:CVD)
CAPS Rating:
A drug development services company providing a range of early stage and late stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries.
RSS Headlines
Fool UK
Recs
Good investment for the long-term...